{"schema_version":"secwatch.filing_event.v1","accession":"0000805928-23-000017","form_type":"8-K","ticker":"AXGN","cik":"0000805928","company_name":"Axogen, Inc.","filed_at":"2023-03-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:48.132682+00:00","generated_at":"2026-06-18T04:04:42.088062+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Axogen reports Q4 revenue $36.2M (+17% YoY); guides FY2023 revenue $154M-$159M","bullets":["Q4 revenue $36.2M, up 17% YoY; gross margin 83.0%; net loss $5.4M ($0.13/sh).","Full-year 2022 revenue $138.6M, up 12% YoY; adjusted net loss $12.6M.","Cash and investments $55.0M at Dec 31, 2022; notes $8M at SVB now accessible.","2023 revenue guidance $154M-$159M; gross margin expected ~80% by Q4 2023.","Active Accounts 968; Core Accounts 332; 115 direct sales representatives."],"urls":{"canonical":"https://secwatch.observer/filing/0000805928-23-000017","json":"https://secwatch.observer/filing/0000805928-23-000017.json","markdown":"https://secwatch.observer/filing/0000805928-23-000017.md","text":"https://secwatch.observer/filing/0000805928-23-000017.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/805928/000080592823000017/0000805928-23-000017-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/805928/000080592823000017/axgn-20230314.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T04:04:42.088062+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1a51dded45130344d7615ed37f596b2e8ed141f2","claim":"Axogen, Inc. reported fourth quarter ended December 31, 2022 results: revenue $36.2 million, net income $5.4 million, EPS $0.13 per share.","evidence_excerpt":"Fourth Quarter 2022 Financial Results and Business Highlights • Fourth quarter revenue was $36.2 million, a 17% increase compared to fourth quarter of 2021.* • Gross margin was 83.0% for the fourth quarter compared to 82.8% in the fourth quarter of 2021.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/805928/000080592823000017/0000805928-23-000017-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fourth quarter ended December 31, 2022"},{"label":"Revenue","value":"$36.2 million"},{"label":"Net income","value":"$5.4 million"},{"label":"EPS","value":"$0.13 per share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"d8d5921d5331a62aa095d99c10122be3babcd7c6","claim":"Axogen, Inc. reported full year 2023 results: revenue $154 million to $159 million. Guidance initiated.","evidence_excerpt":"Management expects full-year 2023 revenue to be in the range of $154 million to $159 million","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/805928/000080592823000017/0000805928-23-000017-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"full year 2023"},{"label":"Revenue","value":"$154 million to $159 million"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"},{"claim_id":"f3b4a9e7edaa7a5b49ce4ea2ba6c5994aa134767","claim":"Axogen, Inc. reported full year ended December 31, 2022 results: revenue $138.6 million.","evidence_excerpt":"ved hospital operating environment and commercial execution, backed by our high-quality portfolio of clinical data provides a solid foundation for long term, sustainable growth.” Full-Year Financial Results and Business Highlights • Full-year 2022 revenue was $138.6 million, a 12% increase compared to 2021 revenue of $127.4 million.* • Gross margin was 82.6% for the full year, compared to 82.0% in 2021.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/805928/000080592823000017/0000805928-23-000017-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"full year ended December 31, 2022"},{"label":"Revenue","value":"$138.6 million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}